Covidien - world's fifth largest healthcare products company - begins trading
This article was originally published in Clinica
Executive Summary
Covidien, the former healthcare division of the $41bn conglomerate Tyco International, made its debut as an independent company on the New York Stock Exchange and in Bermuda on Monday (July 2). The move comes nearly a year after Tyco International first revealed it was considering splitting up into three separate and more manageable businesses.
You may also be interested in...
Confirmed: Siemens Aims For H1 2018 IPO for Healthineers
Siemens is planning to spin out its Healthineers business in an IPO slated for the first half of next year, the German conglomerate has confirmed. The move will give the health care business "the required currency and entrepreneurial flexibility" to grow in a fundamentally attractive market, it said. The announcement was made in conjunction with the group's reporting of its third quarter results for fiscal 2017, in which solid diagnostics imaging sales helped to boost the top line for Healthineers.
Confirmed: Siemens Aims For H1 2018 IPO for Healthineers
Siemens is planning to spin out its Healthineers business in an IPO slated for the first half of next year, the German conglomerate has confirmed. The move will give the health care business "the required currency and entrepreneurial flexibility" to grow in a fundamentally attractive market, it said. The announcement was made in conjunction with the group's reporting of its third quarter results for fiscal 2017, in which solid diagnostics imaging sales helped to boost the top line for Healthineers.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”